Literature DB >> 29931545

Can epilepsy be treated by antibiotics?

Hilde M H Braakman1, Jakko van Ingen2.   

Abstract

There is mounting evidence for the role of the gut microbiota and gut-brain interactions in neurological diseases. We present six patients with drug-resistant epilepsy who attained temporary seizure freedom during antibiotic treatment. The effect on seizure frequency waned within 2 weeks after cessation of antibiotic treatment. We hypothesized that antibiotic treatments may have a short-term effect, through gut microbiota disruption, on gut-brain interactions and ultimately seizure frequency. This observed impact of antibiotics on seizure frequency hints at a possible role of the gut microbiota in epilepsy and its manifestations. This begs the question: can epilepsy be treated by antibiotics? Or perhaps in a broader sense: can alterations in the gut microbiota be used as a treatment modality in drug-resistant epilepsy? This concept and the six intriguing cases provide interesting leads for epilepsy management.

Entities:  

Keywords:  Antibiotics; Epilepsy; Ketogenic diet; Microbiome

Mesh:

Substances:

Year:  2018        PMID: 29931545     DOI: 10.1007/s00415-018-8943-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

Review 1.  Drug-resistant epilepsy.

Authors:  Patrick Kwan; Steven C Schachter; Martin J Brodie
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

Review 2.  Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.

Authors:  Claudiu T Supuran
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-03-03       Impact factor: 4.481

3.  Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.

Authors:  Sahand Imani; Hergen Buscher; Debbie Marriott; Sheridan Gentili; Indy Sandaradura
Journal:  J Antimicrob Chemother       Date:  2017-10-01       Impact factor: 5.790

Review 4.  The gut microbiome in human neurological disease: A review.

Authors:  Helen Tremlett; Kylynda C Bauer; Silke Appel-Cresswell; Brett B Finlay; Emmanuelle Waubant
Journal:  Ann Neurol       Date:  2017-03-20       Impact factor: 10.422

5.  The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet.

Authors:  Christine A Olson; Helen E Vuong; Jessica M Yano; Qingxing Y Liang; David J Nusbaum; Elaine Y Hsiao
Journal:  Cell       Date:  2018-07-12       Impact factor: 41.582

6.  Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy.

Authors:  Gan Xie; Qian Zhou; Chuang-Zhao Qiu; Wen-Kui Dai; He-Ping Wang; Yin-Hu Li; Jian-Xiang Liao; Xin-Guo Lu; Su-Fang Lin; Jing-Hua Ye; Zhuo-Ya Ma; Wen-Jian Wang
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  6 in total
  15 in total

1.  Investigation of the association between imbalance of the intestinal flora and infantile spasms: a pilot case-control study.

Authors:  Lin Wan; Guang Yang; Shan Zhang; Yulin Sun; Zhichao Li; Jing Wang; Xiuyu Shi; Liping Zou
Journal:  Transl Pediatr       Date:  2021-04

Review 2.  The gut microbiome and epilepsy.

Authors:  Maria Dahlin; Stefanie Prast-Nielsen
Journal:  EBioMedicine       Date:  2019-05-31       Impact factor: 8.143

3.  The Effects of a Ketogenic Medium-Chain Triglyceride Diet on the Feces in Dogs With Idiopathic Epilepsy.

Authors:  Rachel Pilla; Tsz Hong Law; Yuanlong Pan; Brian M Zanghi; Qinghong Li; Elizabeth J Want; Jonathan A Lidbury; Joerg M Steiner; Jan S Suchodolski; Holger Andreas Volk
Journal:  Front Vet Sci       Date:  2020-12-22

Review 4.  Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics.

Authors:  Manqiu Ding; Yue Lang; Hang Shu; Jie Shao; Li Cui
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

5.  Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms.

Authors:  Chunlong Mu; Anamika Choudhary; Shyamchand Mayengbam; Karlene T Barrett; Jong M Rho; Jane Shearer; Morris H Scantlebury
Journal:  EBioMedicine       Date:  2022-01-25       Impact factor: 8.143

6.  Polysaccharides, Next Potential Agent for the Treatment of Epilepsy?

Authors:  Xuemin Xie; Youliang Wu; Haitao Xie; Haiyan Wang; Xiaojing Zhang; Jiabin Yu; Shaofang Zhu; Jing Zhao; Lisen Sui; Shaoping Li
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

Review 7.  Towards Tailored Gut Microbiome-Based and Dietary Interventions for Promoting the Development and Maintenance of a Healthy Brain.

Authors:  Ana Larroya; Jorge Pantoja; Pilar Codoñer-Franch; María Carmen Cenit
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

Review 8.  The gut microbiome in drug-resistant epilepsy.

Authors:  Simela Chatzikonstantinou; Georgia Gioula; Vasilios K Kimiskidis; Jack McKenna; Ioannis Mavroudis; Dimitrios Kazis
Journal:  Epilepsia Open       Date:  2021-01-13

Review 9.  Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy.

Authors:  Jana Amlerova; Jan Šroubek; Francesco Angelucci; Jakub Hort
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 10.  The Microbiota-Gut-Brain Axis and Epilepsy.

Authors:  Qiang Yue; Mingfei Cai; Bo Xiao; Qiong Zhan; Chang Zeng
Journal:  Cell Mol Neurobiol       Date:  2021-07-19       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.